Importance of Zebrafish as a Non-Mammalian Vertebrate Model for Studying Neurodegenerative Disorders Using Ayurvedic Medicinal Plants: A Review

Subharthi Pal

Department of Zoology, Bhairab Ganguly College, Kolkata, 700056, West Bengal, India.

Anisa Mitra

Department of Zoology, Sundarban Hazi Desarat College, Pathankhali, West Bengal, 743611, India.

Rajarshi Ghosh *

Post Graduate Department of Zoology, Maulana Azad College, Kolkata, 700013, West Bengal, India.

*Author to whom correspondence should be addressed.


Alzheimer's disease and Parkinson's disease are debilitating neurodegenerative disorders that impose a significant burden on the affected individuals and the society as a whole. Despite extensive research efforts, effective treatments for these diseases remain elusive till date. Ayurveda, a traditional system of medicinal practice which originated in ancient India, has long touted the potential of various plants possessing neuroprotective properties. The effects of a few relevant Ayurvedic plants viz. Guduchi, Kapikachhu, Shankhapushpi, Turmeric, Mandukparni, Ashwagadha, Brahmi, Jatamansi etc. on several non-human primates and rodents have been reported. The therapeutic potential of those plants to mitigate the pathological hallmarks associated with Alzheimer's disease and Parkinson's disease was assessed. We have outlined the most recent research on Ayurveda's effects on neurodegenerative brain illnesses in this review article, with an emphasis on Alzheimer's disease and Parkinson's disease. As the zebrafish (Danio rerio Hamilton) has emerged as a useful, non-mammalian vertebrate model organism for studying a wide range of diseases, the effect of few other medicinal plants on zebrafish was also mentioned. Powerful live imaging and genetic tools which is currently available for zebrafish has transformed this fish to a top model in biomedical research and toxicity testing. However, further research is needed to elucidate the precise mechanisms of action and to translate these promising results into clinical applications. The exploration of traditional medicinal systems, in conjunction with modern scientific methodologies using novel model organisms, such as zebrafish offers a valuable avenue for the development of innovative treatments for neurodegenerative disorders.

Keywords: Ayurvedic plants, traditional medicine, Alzheimer's disease, Parkinson's disease, Zebrafish

How to Cite

Pal , S., Mitra, A., & Ghosh , R. (2024). Importance of Zebrafish as a Non-Mammalian Vertebrate Model for Studying Neurodegenerative Disorders Using Ayurvedic Medicinal Plants: A Review. UTTAR PRADESH JOURNAL OF ZOOLOGY, 45(1), 56–70.


Download data is not yet available.


Alzheimer’s association. Alzheimer’s disease facts and figures. Alzheimers & Dementia. 2021;17:327-406. DOI: 10.1002/alz.12328

Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Molecular Medicine. 2016;8: 595-608.

DOI: 10.15252/emmm.201606210

Dorsey ER, Bloem BR. The parkinson pandemic-A call to action. JAMA Neurology. 2018;75:9-10.

Jankovic J. Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery and Psychiatry. 2008;79:368-376.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC. Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy. Moving Disorder. 2017; 32(9):1264-1310.

DOI: 10.1002/mds.27115.

ArmstrongMJ,Okun MS. Diagnosis and treatment of Parkinson disease. JAMA. 2020;323:548-560.

GBD 2016 Parkinson's Disease Collaborators. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. 2018;17(11):939- 953.

DOI: 10.1016/S1474-4422(18)30295-3

Garcia-Ruiz PJ. Prehistoria de la enfermedad de Parkinson (Prehistory of Parkinson's disease). Neurologia (in Spanish). 2004;19(10):735-737.

Abascal K, Yarnell E. Alzheimer’s disease: part 2-A botanical treatment plan. Alternative and Complementary Therapies. 2004;10:67-72.

PerryEK, Pickering AT, WangWW, Houghton PJ, Perry NS. Medicinal plants and Alzheimer’s disease: from ethnobotany to phytotherapy. Journal of Pharmacy and Pharmacology. 1999;51:527-534.

Howes MJ, Perry NS, Houghton PJ. Plants with traditional uses and activities, relevant to the management of Alzheimer’s disease and other cognitive disorders. Phytotherapy Research. 2003;17:1-18.

Kennedy DO, Wightman EL. Herbal extracts and phytochemicals: Plant secondary metabolites and the enhancement of human brain function. Advances in Nutrition. 2011;2:32-50.

Kumar V. Potential medicinal plants for CNS disorders: An overview. Phytotherapy Research. 2006;20:1023-1035.

Manyam BV. Dementia in ayurveda. The Journal of Alternative and Complementary Medicine.1999;5:81-88.

Kelley BJ, Knopman DS. Alternative medicine and Alzheimer disease. Neurologist. 2008;14:299-306.

Mishra, LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withaniasomnifera (ashwagandha): A review. Alternative Medicine Review. 2000; 5:334-346.

Mukherjee PK. Evidence-based validation of herbal medicine: Translational approach. 2nd Edition. Elsevier; 2022.

Sharma S, Sharma S, Chourasia R, Pandey A, Rai AK, Sahoo D. Chapter 2 - Alzheimer’s disease: Ethnobotanical studies. Naturally Occurring Chemicals Against Alzheimer's Disease. Academic Press. 2021;11-28.

Mutalik M, Mutalik M. Tinosporacordifolia and its varied activities: What is believed and what is known?International Journal of Current Research and Review. 2011;3:94-109.

Mishra R, Manchanda S, Gupta M, Kaur T, Saini V, Sharma A, Kaur G. Tinospora cordifolia ameliorates anxiety-like behavior and improves cognitive functions in acute sleep deprived rats. Scientific Reports. 2016;6:255-264.

DOI: 10.1038/srep25564

Gupta A, Raj H, Karchuli, MS, Upmanyu N. Comparative evaluation of ethanolic extracts of Bacopa monnieri, Evolvulusalsinoides, Tinospora cordifoli-aand their combinations on cognitive functions in rats. Current Aging Science. 2013;6(3):239-243.

DOI: 10.2174/18746098112059990036

Sharma A, Kaur G. Tinospora cordifolia as a potential neuroregenerative candidate against glutamate induced excitotoxicity: An in vitro perspective. BMC Complement Alternative Medicine. 2018;18(1):268.

DOI: 10.1186/s12906-018-2330-6

23.Manyam BV. Paralysis agitans and levodopa in ‘Ayurveda’: Ancient Indian medical treatise. Movement Disorders. 1990;5(1):47-48.

DOI: 10.1002/mds.870050112

PMID: 2404203

Manyam B, Sanchez-Ramos JR. Traditional and complementary therapies in Parkinsons disease. Advanced Neurology. 1999;80: 565-574.

Cilia R, Laguna J, Cassani E, Cereda E, Pozzi NG, Isaias IU, Contin M, Barichella M, Pezzoli, G. Mucunapruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study. Neurology. 2017;89(5):432-438.

DOI: 10.1212/WNL.0000000000004175

Lieu CA, Kunselman AR, Manyam BV, Venkiteswaran K, Subramanian T. A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. Parkinsonism & Related Disorders. 2010;16(7):458- 465.

DOI: 10.1016/j.parkreldis.2010.04.015

Johnson SL, Park HY, Dasilva NA, Vattem DA, Ma H, Seeram NP. Levodopa-reduced Mucunapruriens seed extract shows neuroprotective effects against Parkinson’s disease in murine microglia and human neuroblastoma cells, Caenorhab-ditiselegans, and Drosophila melanogaster. Nutrients. 2018;10:1-14.


28.Vaidya AB, Rajagopalan TG, Mankodi NA, Antarkar DS, Tathed PS, Purohit AV, Wadia NH. Treatment of Parkinson's disease with the cowhage plant-Mucunapruriens Bak. Neurology India. 1978;26(4):171-176.

Balkrishna A, Thakur P, Varshney A. Phytochemical profile, Pharmacological attributes and medicinal properties of convolvulus prostratus – A Cognitive Enhancer Herb for the Management of Neurodegenerative Etiologies. Frontiers in Pharmacology. 2020;11:171.

DOI: 10.3389/fphar.2020.00171

Saroya AS, Singh J. Pharmacotherapeutic Potential of Natural Products in Neurological Disorders. Springer Singapore; 2018.

Malik J, Karan M, Vasisht K. Noo tropic, anxiolytic and CNS-depressant studies on different plant sources of shankhpushpi. Pharmaceutical Biology. 2011;49:1234-1242.

Singh RH, Narsimhamurthy K, Singh G. Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology. 2008;9:369-374.

Nahata A, Patil UK, Dixit VK. Effect of ConvulvuluspluricaulisChoisy on learning behaviour and memory enhancement activity in rodents. Natural Product Research. 2008;22:1472-1482.

Sharma K, Bhatnagar M, Kulkarni SK. Effect of Convolvulus pluricaulis Choisy and Asparagus racemosus Wild on learning and memory in young and old mice: A comparative evaluation. Indian Journal of Experimental Biology. 2010;48: 479-485.

Rai KS, Murthy KD, Rao MS, Karanth KS. Altered dendritic arborization of amygdala neurons in young adult rats orally intubated with Clitoreaternatea aqueous root extract. Phytotherapy Research. 2005;19:592-598.

Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: The Indian solid gold. Advances in Experimental Medicine and Biology. 2007;595:1-75.

Begum AN, Jones MR, Lim GP, Morihara T, Kim, P, Heath, DD, Rock CL, Pruitt MA, Yang F, Hudspeth B, Hu S, Faull KF, Teter B, Cole GM, Frautschy SA. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease. Journal of Pharmacology and Experimental Therapeutics. 2008;326:196-208.

Goel A, Ajaikumar BK, Aggarwal BB. Curcumin as Curecumin: from kitchen to clinic. Biochemical pharmacology. 2008;75. 4:787-809.

Satheeshkumar N, Vijayan RSK, Lingesh A, Santhikumar S, Vishnuvardhan C. Spices: Potential therapeutics for alzheimer’s disease. In: Essa, M., Akbar, M., Guillemin, G. (eds.) The benefits of natural products for neurodegenerative diseases. Advances in Neurobiology. Springer, Cham. 2016;12.


Lee W H, Loo CY, Bebawy M, Luk F, Mason R, Rohanizadeh R. Curcumin and its derivatives: Their application in neuropharmacology and neuroscience in the 21st century. Current Neuro-pharmacology. 2013;11:338–78.


Pluta R, Ułamek-Kozioł M, Czuczwar SJ. Neuroprotective and neurological/cognitive enhancement effects of curcumin after brain ischemia injury with alzheimer’s disease phenotype. International Journal of Molecular Sciences. 2018;19.


Yavarpour-Bali H, Pirzadeh M, Ghasemi-Kasman M. Curcumin-loaded nanoparticles: A novel therapeutic strategy in treatment of central nervous system disorders. International Journal of Nano-medicine. 2019;14:4449–4460.

DOI: 10.2147/IJN.S208332

Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, Juyal RC, Pandav R, Belle SH, DeKosky ST. Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Archives of Neurology. 2000;57:824-830.

Breitner JC, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, Pericak-Vance M A, Saunders AM. Delayed onset of Alzheimer’s disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiology Aging. 1995;16:523-530.

Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM (). The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. Journal of Neuro-science.2001;21:8370-8377.

Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM. Curcumin inhibits formation of amyloid beta oligomers and fi brils, binds plaques, and reduces amyloid in vivo. Journal of Biological Chemistry. 2005;280:5892-5901.

Xu Y, Ku B, Cui L, Li X, Barish PA, Foster TC, Ogle WO. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Research. 2007;8;1162:9-18. DOI: 10.1016/j.brainres.2007.05.071

Kelley BJ, Knopman DS. Alternative medicine and Alzheimer disease. Neurologist. 2008;14:299-306.

Sharma R, Kuca K, Nepovimova E, Kabra A, Rao MM, Prajapati P K. Traditional ayurvedic and herbal remedies for alzheimer's disease: from bench to bedside. Expert Review of Neurothera-peutics. 2019;19(5):359-374.

DOI: 10.1080/14737175.2019.1596803

Belkacemi A, Doggui S, Dao L, Ramassamy C. Challenges associated with curcumin therapy in Alzheimer disease. Expert Reviews in Molecular Medicine. 2011;13:e34.

Chopra RN, Nayar SL, Chopra IC. Glossary of Indian medicinal plants (Including the Supplement) New Delhi: Council of Scientific and Industrial Research. 1986;51–83.

Diwan PC, Karwande I, Singh AK. Anti-anxiety profile of mandukparni Centellaasiatica Linn in animals. Fitoterapia. 1991;62:255–257.

Shinomol GK, Muralidhara Bharath, MM. Exploring the role of ‘Brahmi’ (Bocopamonnieriand Centellaasiatica) in brain function and therapy. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery. 2011;5:33-49.

Cervenka F, Jahodár L. Plant metabolites as nootropics and cognitives. Ceska a Slovenska Farmacae. 2006;55(5):219-229.

Dhanasekaran M, Holcomb LA, Hitt AR, Tharakan B, Porter JW, Young KA, Manyam BV. Centellaasiaticaextract selectively decreases amyloid beta levels in hippocampus of Alzheimer’s disease animal model. Phytotherapy Research. 2009;23:14-19.

Yadav MK, Singh SK, Singh M, Mishra SS, Singh AK, Tripathi JS, Tripathi YB. Neuroprotective activity of Evolvulusalsinoides & Centellaasiatica ethanolic extracts in scopolamine-induced amnesia in swiss albino mice. Open Access Macedonian Journal of Medical Sciences 2019;7(7):1059-1066.

DOI: 10.3889/oamjms. 2019.247

Denhaan J, Morrema THJ, Rozemuller AJ, Bouwman FH, Hoozemans JJM. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer’s disease brains: Implications for in-vivo diagnostics. Acta Neuropathologica Communications. 2018;6:75.


Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withaniasomnifera (ashwagandha): A review. Alternative Medicine Review. 2000; 5:334-346.

Wollen KA. Alzheimer’s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Alternative Medicine Review. 2010;15:223-244.

Dar NJ. Neurodegenerative diseases and Withaniasomnifera (L.): An update.Journal of Ethnopharmacology. 2020;11:27-69.

Kulkarni SK, Ashish D. Withaniasomnifera: An Indian ginseng. Progress in neuro-psychopharmacology and biological psychiatry. 2008;32.5:1093-1105.

Nema, R, Jain P, Khare S, Pradhan A, Gupta A, Singh D. Study of Withaniasomnifera with the special reference of phytochemical, FTIR and flavonoids quantification. International Journal of Pharmacy & Life Sciences. 2012;3(3):1530.

Jayaprakasam B, Padmanabhan K, Nair MG. Withanamides in Withania-somniferafruit protect PC-12 cells from beta-amyloid responsible for Alzheimer’s disease. Phytotherapy Research. 2010;24: 859-863.

Kumar S, Harris R J, Seal CJ, Okello, E J. An aqueous extract of Withania-somniferaroot inhibits amyloid beta fibril formation in vitro. Phytotherapy Research. 2012;26:113-117.

Kuboyama T, Tohda C, Zhao J, Nakamura N, Hattori M, Komatsu K. Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. NeuroReport. 2002;13:1715-1720.

Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V. Systemic administration of defined extracts from Withaniasomnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochemistry International. 1997;30: 181-190.

Rao RV, Descamps O, John V, Bredesen DE. Ayurvedic medicinal plants for Alzheimer's disease: a review. Alzheimer's Research & Therapy. 2012; 29.4(3): 22.

DOI: 10.1186/alzrt125

Rajasankar S, Manivasagam T, Surendran S. Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson’s disease. NeuroscienceLetter. 2009;454:11-15.

Gupta M, Kaur G. Withaniasomnifera (L.) Dunal ameliorates neurodegeneration and cognitive impairments associated with systemic inflammation. BMC complementary and alternative medicine. 2019;19.1:1-18.

Kumar V. Potential medicinal plants for CNS disorders: An overview. Phytotherapy Research. 2006;20:1023-1035.

Stough C, Downey LA, Lloyd J, Silber B, Redman S, Hutchison C, Wesnes K, Nathan PJ. Examining the nootropic effects of a special extract of Bacopa-monnieraon human cognitive functioning: 90-day double-blind placebo controlled randomized trial. Phytotherapy Research. 2008;22:1629-1634.

Bacopamonniera. Monograph. Alternative Medicine Review. 2004;9:79-85.

Dubey T, Chinnathambi, S. Brahmi (Bacopamonnieri): An ayurvedic herb against the Alzheimer's disease. Archives of Biochemistry and Biophysics. 2019;108-153.

Chaudhari KS, Tiwari NR, Tiwari RR, Sharma RS. Neurocognitive effect of nootropic drug Brahmi (Bacopamonniera) in Alzheimer's Disease. Annals of Neurosciences. 2017;24(2):111-122.

DOI: 10.1159/000475900.

Uabundit N, Wattanathorn J, Mucimapura S, Ingkaninan K. Cognitive enhancement and neuroprotectiveeffects of Bacopa-monnieriin Alzheimer’s disease model. Journal of Ethnopharmacology. 2010;127: 26-31.

Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal S. Antioxidant activity of Bacopamonnierain rat frontal cortex, striatum and hippocampus. Phytotherapy Research. 2000;14:174-179.

Drozdov OL, VI Chorna. Changes in the content of glial fibrillary acidic protein in the frontal cortex of rats during conditioned active avoidance training. Neuro-physiology. 2003;35.2:98-101.

Holcomb LA, Dhanasekaran M, Hitt AR, Young KA, Riggs M, Manyam BV. Bacopamonniera extract reduces amyloid levels in PSAPP mice.Journal of Alzheimer's Disease. 2006;9(3):243-51.

DOI: 10.3233/jad-2006-9303

Konar A, Gautam A, Thakur MK. Bacopa monniera (CDRI-08) upregulates the expression of neuronal and glial plasticity markers in the brain of scopolamine induced amnesic mice. Evidance Based Complementary and Alternative Medicine. 2015;837012.

DOI: 10.1155/2015/837012.

Pravina K, Ravindra KR, Goudar KS, Vinod DR, Joshua AJ, Wasim P, Venkateshwarlu K, Saxena VS, Amit A. Safety evaluation of BacoMind in healthy volunteers: A phase I study. Phytomedicine. 2007;14:301-308.

Roodenrys S, Booth D, Bulzomi S, Phipps A, Micallef C, Smoker J. Chronic effects of Brahmi (Bacopamonnieri) on human memory. Neuropsychopharmacology. 2002;27:279-281.

Nathan PJ, Clarke J, Lloyd J, Hutchison CW, Downey L, Stough C. The acute effects of an extract of Bacopamonniera (Brahmi) on cognitive function in healthy normal subjects. Human Psycho-pharmacology. 2001;16:345-351.

Rao RV, Descamps O, John V, Bredesen DE. Ayurvedic medicinal plants for Alzheimer's disease: a review. Alzheimer's Research & Therapy.2012;29;4(3):22.

DOI: 10.1186/alzrt125

Lyle N, Gomes A, Sur T, Munshi S, Paul S, Chatterjee S, Bhattacharyya D. The role of antioxidant properties of Nardosta-chysjatamansi in alleviation of the symptoms of the chronic fatigue syndrome. Behavioural Brain Research 2009:14; 202(2):285-90.

DOI: 10.1016/j.bbr.2009.04.005

Shankar A, Shankar A, Shankar A. Parkinson disease and Ayurveda. Journal of Neurology & Stroke. 2019;9(5):249- 253.

DOI: 10.15406/jnsk.2019.09.00384.

Gharibi A, Khalili M, Kiasalari Z, Hoseinirad M. The effect of Zingiber officinalis L. on learning and memory in rats. Journal of Basic and Clinical Pathophysiology. 2013; 2:2013-2014.

Vasudevan M, Parle M. Memory enhancing activity of Anwalachurna (Emblica officinalisGaertn.): An Ayurvedic preparation. Physiology & behaviour. 2007; 91.1:46-54.

Obulesu M, Rao DM. Effect of plant extracts on Alzheimer’s disease: An insight into therapeutic avenues. Journal of neurosciences in rural practice. 2011; 2.01:056-061.

Sharma R, Kuca K, Nepovimova E, Kabra A, Rao MM, Prajapati PK. Traditional ayurvedic and herbal remedies for alzheimer's disease: from bench to bedside. Expert Rev Neurother. 2019;19 (5):359-374.

DOI: 10.1080/14737175.2019.1596803

Roy C, Ghosh TK, Guha D. The antioxidative role of Benincasa hispida on colchicine induced experimental rat model of Alzheimer's disease. Biogenic Amines. 2007;21.1/2: 42.

Rai KS, Murthy KD, Karanth KS, Nalini K, Rao MS, Srinivasan KK. Clitoriaternatea root extract enhances acetylcholine content in rat hippocampus. Fitoterapia. 2002;73(7-8):685-689.

DOI: 10.1016/s0367-326x(02)00249-6

Lobay D. Rauwolfia in the treatment of hypertension. Integrative Medicine: A Clinician's Journal. 2015;14.3: 40.

Kandhan TS, Nazer MR, Thangavelu L, Roy A. Acetylcholinesterase activity of Ocimum sanctum leaf extract. Journal of Advanced Pharmacy Education and Research. 2018;8(1):41- 44.

Dubey T, Chinnathambi S. Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease. Archives of Biochemistry &Biophysics. 2019;676:108-153.

DOI: 10.1016/

Mansoorali KP, Prakash T, Kotresha D, Prabhu K, Rama Rao N. Cerebroprotective effect of Eclipta alba against global model of cerebral ischemia induced oxidative stress in rats. Phytomedicine. 2012;19 (12):1108-16.

DOI: 10.1016/j.phymed.2012.07.004

Farkhondeh T, Samarghandian S, Shaterzadeh Yazdi H, Samini F. The protective effects of crocin in the management of neurodegenerative diseases: A review. The American Journal of Neurodegenerative Disease. 2018; 5.7(1):1-10.

Gorji N, Moeini R, Memariani Z. Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer's disease: A neuropharmacological review of their bioactive constituents. Pharmacological Research. 2018;129:115-127.

DOI: 10.1016/j.phrs.2017.12.003

Chauhan NB. Multiplicity of garlic health effects and Alzheimer's disease. The Journal of Nutrition, Health & Aging. 2005;9(6):421-32.

Pienaar IS, Gotz J, Feany MB. Parkinson’s disease: Insights from non-traditional model organisms. Progress in Neurobiology. 2010; 92:558-571.

Lieschke GJ, Trede NS. Fish immunology. Current Biology 2009;19(16):678-682.

DOI: 10.1016/j.cub.2009.06.068

Rennekamp AJ, Peterson RT. 15 years of zebrafish chemical screening. Current Opinion in Chemical Biology. 2015;24: 58-70.

Pavlidis M, Theodoridi A, Tsalafouta A. Neuroendocrine regulation of the stress response in adult zebrafish, Danio rerio. Progress in neuro-psychopharmacology & biological psychiatry. 2015;60:121-131.

Kokel, D, Peterson, RT.Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish. Briefings in Functional Genomics & Proteomics. 2008;7(6):483-490.

Khotimah H, Sumitro SB, Ali M, Widodo MA. Standardized centella asiatica increased brain derived neurotrophic factor and decreased apoptosis of dopaminergic neuron in rotenone-induced zebrafish. GSTF Journal of Psychology. 2015;1:22-27.

Mohanty R, Das SK, Singh NR, Patri M. Withaniasomnifera leaf extract ameliorates benzo[a] pyrene-induced behavioral and neuromorphological alterations by improving brain antioxidant status in zebrafish (Danio rerio). Zebrafish. 2016;13 (3):188-196.

Maddula K, Kumar VP, Anusha J. Assessment of Aqueous Extract of Ocimum sanctum Leaves in Memory Enhancement and Preventing Memory Impairment Activities in Zebra Fish Model. Journal of Basic and Clinical Pharmacy. 2017;8(3):185-192.

Abidar S, Boiangiu RS, Dumitru G, Todirascu-Ciornea E, Amakran A, Cioanca O, Hritcu L, Nhiri M. The aqueous extract from Ceratonia siliqua Leaves protects against 6-hydroxydopamine in zebrafish: Understanding the Underlying Mechanism. Antioxidants. 2020;9(4):304.

DOI: 10.3390/antiox9040304

Ngadni MA, Akhtar MT, Ismail IS, Norazhar AI, Lee SY, Maulidiani M, Shaari K. Clitorienolactones and Isoflavonoids of Clitoreaternatea Roots Alleviate Stress-Like Symptoms in a Reserpine-Induced Zebrafish Model. Molecules. 2021;26 (14):4137.

DOI: 10.3390/molecules26144137

Grosso C, Valentão P, Andrade PB. Depressive disorders: Prevalence, costs, and theories, Herbal Medicine in Depression. Springer. 2016;1-41.

Muniandy Y. The role of zebrafish larvae for studying anxiety-like behaviour. Universiteit Leiden thesis; 2019.

Puttarak P, Dilokthornsakul P, Saokaew S, Dhippayom T, Kongkaew C, Sruamsiri R, Chuthaputti A, Chaiyakunapruk N. Effects of Centella asiatica (L.) Urb. on cognitive function and mood related outcomes: A systematic review and meta- analysis. Scientific Report. 2017;7(1): 10646.

DOI: 10.1038/s41598-017-09823-9

Chapela D, Sousa S, Martins I, Cristóvão AM, Pinto P, Corte-Real S, Saúde L. A zebrafishdrug screening platform boosts the discovery of novel therapeutics for spinal cord injury in mammals. Scientific Report. 2019;9(1):10475. DOI: 10.1038/s41598-019-47006-w

Best J, Alderton WK. Zebrafish: An in vivo model for the study of neurological diseases. Neuropsychiatric Disease and Treatment. 2008;4(3): 567-576. DOI: 10.2147/ndt.s2056

Tavares B, Santos Lopes S. The importance of Zebrafish in biomedical research. Acta Medica Portuguesa. 2013; 26(5): 583-592.

Rao RV, Descamps O, John V, Bredesen DE. Ayurvedic medicinal plants for Alzheimer's disease: A review. Alzheimer's research & therapy. 2012;4:1-9.